T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Hovnanian Enterprises
HOV
$793M
| $1.24M | ﹤0.01% |
7,917
+188
| +2% | +$29K |
|
1802
Lucid Motors
LCID
$2.54B
| $1.24M | ﹤0.01% |
43,579
+2,375
| +6% | +$75.7K |
|
1803
Opendoor
OPEN
$3.54B
| $1.24M | ﹤0.01% |
423,359
-227,828
| -35% | -$711K |
|
1804
Newmark Group
NMRK
$2.68B
| $1.24M | ﹤0.01% |
111,296
+4,779
| +4% | +$50K |
|
1805
Brookfield Infrastructure
BIPC
$4.93B
| $1.23M | ﹤0.01% |
34,225
+4,361
| +15% | +$153K |
|
1806
Northwest Natural Holdings
NWN
$2.12B
| $1.23M | ﹤0.01% |
32,999
+7,715
| +31% | +$288K |
|
|
KAMN
1807
DELISTED
Kaman Corp
KAMN
| $1.23M | ﹤0.01% |
26,771
+1,008
| +4% | +$41.4K |
|
1808
Worthington Enterprises
WOR
$2.78B
| $1.23M | ﹤0.01% |
19,682
+1,119
| +6% | +$66.6K |
|
1809
Corcept Therapeutics
CORT
$12.1B
| $1.22M | ﹤0.01% |
48,426
-3,109
| -6% | -$73.5K |
|
1810
First Bancorp
FBNC
$2.72B
| $1.22M | ﹤0.01% |
33,690
+1,434
| +4% | +$50K |
|
1811
Millicom
TIGO
$15.8B
| $1.22M | ﹤0.01% |
+60,080
| New | +$1.07M |
|
1812
MaxLinear
MXL
$6.95B
| $1.22M | ﹤0.01% |
65,031
-1,693,505
| -96% | -$33.8M |
|
1813
Hilltop Holdings
HTH
$2.25B
| $1.21M | ﹤0.01% |
38,736
+1,635
| +4% | +$52K |
|
|
AVNS
1814
DELISTED
Avanos Medical
AVNS
| $1.21M | ﹤0.01% |
60,898
-192
| -0.3% | -$3.71K |
|
1815
PROG Holdings
PRG
$1.64B
| $1.21M | ﹤0.01% |
35,164
-25,704
| -42% | -$808K |
|
1816
Appian
APPN
$2.49B
| $1.2M | ﹤0.01% |
30,097
+1,494
| +5% | +$51.8K |
|
|
VRN
1817
DELISTED
Veren
VRN
| $1.2M | ﹤0.01% |
146,788
| – | – |
|
1818
Metallus
MTUS
$900M
| $1.2M | ﹤0.01% |
53,976
+1,387
| +3% | +$28.9K |
|
|
JBGS
1819
JBG SMITH
JBGS
$691M
| $1.19M | ﹤0.01% |
74,311
+1,824
| +3% | +$30.4K |
|
|
B
1820
DELISTED
Barnes Group Inc.
B
| $1.19M | ﹤0.01% |
32,079
+1,672
| +5% | +$57.5K |
|
1821
Chefs' Warehouse
CHEF
$4.53B
| $1.19M | ﹤0.01% |
31,563
+1,223
| +4% | +$41.9K |
|
1822
Sunstone Hotel Investors
SHO
$2.01B
| $1.19M | ﹤0.01% |
106,553
+6,439
| +6% | +$70.3K |
|
|
TWO
1823
Two Harbors Investment
TWO
$1.27B
| $1.19M | ﹤0.01% |
89,702
+5,284
| +6% | +$68.8K |
|
1824
AAR Corp
AIR
$5.96B
| $1.19M | ﹤0.01% |
19,805
+1,249
| +7% | +$77.8K |
|
|
DVAX
1825
DELISTED
Dynavax Technologies
DVAX
| $1.19M | ﹤0.01% |
95,537
+9,839
| +11% | +$128K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.